GSK plc (ADR)

General ticker "GSK" information:

  • Sector: Health Care
  • Industry: Drug Manufacturers - General
  • Capitalization: $78.8B (TTM average)

GSK plc (ADR) follows the US Stock Market performance with the rate: 44.3%.

Estimated limits based on current volatility of 1.1%: low 55.71$, high 56.98$

Factors to consider:

  • Company pays dividends (quarterly): last record date 2026-02-20, amount 0.48$ (Y3.47%)
  • Total employees count: 99451 as of 2013

Stock Forecast*

* forecast is subjective and experimental, should not be used for any investment decisions

Long term estimates were made for the period from 2025-12-31 to 2027-12-31

  • 2025-12-31 to 2026-12-31 estimated range: [38.41$, 57.23$]
  • 2026-12-31 to 2027-12-31 estimated range: [42.29$, 62.06$]

Similar symbols

Short-term GSK quotes

Long-term GSK plot with estimates

Financial data

YTD 2023-12-31 2024-12-31 2025-12-31
Operating Revenue £30,328.00MM £31,376.00MM £31,951.12MM
Operating Expenses £23,583.00MM £27,355.00MM £24,939.22MM
Operating Income £6,745.00MM £4,021.00MM £7,011.89MM
Non-Operating Income £-681.00MM £-544.00MM £226.92MM
Interest Expense £775.00MM £657.58MM £685.64MM
R&D Expense £6,223.00MM £6,401.00MM £7,343.47MM
Income(Loss) £6,064.00MM £3,477.00MM £7,238.81MM
Taxes £756.00MM £526.00MM £1,087.63MM
Profit(Loss)* £4,928.00MM £2,575.00MM £5,590.74MM
Stockholders Equity £17,014.76MM £13,671.00MM £16,348.21MM
Inventory £7,008.85MM £5,669.00MM £5,913.59MM
Assets £75,219.57MM £59,463.00MM £61,010.57MM
Operating Cash Flow £7,890.89MM £6,554.00MM £7,142.96MM
Capital expenditure £1,633.37MM £2,982.00MM £1,318.46MM
Investing Cash Flow £-2,404.06MM £-1,229.00MM £-5,722.78MM
Financing Cash Flow £-6,068.58MM £-4,726.00MM £-1,593.30MM
Earnings Per Share** £2.43 £1.26 £2.76
Ordinary share to ADR 1.00x 1.00x 1.00x

* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.